ADLINE CHEM LAB LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 13.36 INR | -4.98% |
|
-14.08% | -50.13% |
| 03-05 | Adline Chem Lab CFO Steps Down | MT |
| 03-05 | Adline Chem Lab Limited Announces CFO Changes | CI |
Adline Chem Lab Limited, formerly Kamron Laboratories Limited, is an India-based pharmaceutical company. The Company is operating in one segment: pharmaceutical products. The Company's products for the domestic market include anti-infectives, bone health, gastroenterology care, hemostatic, multi-vitamins, pediatric care, pain and inflammation, pregnancy and reproductive care, respiratory care and hepatocare. The Company's products for the international market include tablets, capsules and injections. The Company's veterinary products include B Complex Liver Extract With Vitamin B12 Inection, Chlorpheniramine Injection IP, Triflupromazine Hydrochloride Injection IP, Triamcinolone Acctonide Injection IP, Triamcinolone Acetonide IP and Tetracyclin-bolus Tablets. The Companyâs educational supplements include Demo-Dose Dyaz, Demo-dose colac, Demo-Dose Dilat and Demo-Eose eryth.
Sector
Pharmaceuticals
Calendar
12/08/2024
- Q1 2025 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| -50.13% | 936K | |
| +20.37% | 43.54B | |
| +19.44% | 21.78B | |
| +17.85% | 15.38B | |
| +25.55% | 15.12B | |
| +60.99% | 13.36B | |
| -0.05% | 6.79B | |
| -15.02% | 6.38B | |
| -8.87% | 5.73B | |
| +8.17% | 5.32B |
- Stock Market
- Equities
- KAMRLAB Stock
- News Adline Chem Lab Limited
- Adline Chem Lab Appoints CFO